EWEnlin Wang

Enlin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Enlin Wang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Shian Wu

    Department of Genetics and Cell Biology, College of Life Sciences, Nankai University

    2 shared publications
  • Bing Wei

    The Second Hospital of Anhui Medical University

    1 shared publication
  • Chaojun Zhai

    The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, China

    1 shared publication
  • Chenxi Qian

    College of Life Sciences, Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, 300071 Tianjin, PR China

    1 shared publication
  • Guangshuang Shen

    The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, China

    1 shared publication
  • Guiping Wang

    The State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Protein Sciences, College of Life Sciences, Nankai University, Tianjin 300071, China

    1 shared publication

Latest Publications

  • Open Access

    High expression of KIF4A predicts poor prognosis hallmark and is correlated with immune infiltrates in cervical cancer

    by Xiaofeng Ma, Yun Lu, Bing Wei, Wenyan Wang, Enlin Wang

    Background Cervical cancer (CC) has become the fourth most common cancer among women and cause a larger number of deaths in worldwide. Screening at the early stage of CC is an effective precaution. Discovery of the new hallmark of CC will provide a guidance for CC screening. Kinesin family member 4A (KIF4A) expressed in a variety of tissues and also contributed to development of several cancers, however its function in CC remains unclear.Methods we download and analyzed the clinical information and mRNA profile of cervical cancer patients from TCGA and GTEx database. After normalization process, the expression values of KIF4A were calculated according to TCGA and GTEx data. We collected CC patient tissue samples from the Second Hospital of Anhui Medical University and detected KIF4A expression by IHC and WB. The immune cell infiltration analysis is preformed in the online analysis tool TIMER 2.0 (http://timer.cistrome.org/).Results The high-expression of KIF4A was demonstrated in the CC patients according to the bioinformatics analysis and clinical test. Additionally, loss-function of KIF4A with shRNA abrogated cervical cell proliferation, migration and invasion. We also found that the difference expression genes were identified between KIF4A− high and KIF4A− low CC patients among with abundant mutation of several genes occurred in the CC progression. Finally, we also proved that KIF4A was involved in the immune cell infiltration in the CC patients by clinical information analysis. These demonstrated that the dys-expression of KIF4A may be used for the CC screening and clinical therapy.

  • MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer’s disease

    by Hui Wang, Yingchun Shang, Enlin Wang, Xinxin Xu, Qiyue Zhang, Chenxi Qian, Zhuo Yang, Shian Wu, Tao Zhang


  • Open Access

    Usp10 Modulates the Hippo Pathway by Deubiquitinating and Stabilizing the Transcriptional Coactivator Yorkie

    by Yang Gao, Xiaoting Zhang, Lijuan Xiao, Chaojun Zhai, Tao Yi, Guiping Wang, Enlin Wang, Xiaohui Ji, Liangchang Hu, Guangshuang Shen, et al.

    The Hippo signaling pathway is an evolutionarily conserved regulator that plays important roles in organ size control, homeostasis, and tumorigenesis. As the key effector of the Hippo pathway, Yorkie (Yki) binds to transcription factor Scalloped (Sd) and promotes the expression of target genes, leading to cell proliferation and inhibition of apoptosis. Thus, it is of great significance to understand the regulatory mechanism for Yki protein turnover. Here, we provide evidence that the deubiquitinating enzyme ubiquitin-specific protease 10 (Usp10) binds Yki to counteract Yki ubiquitination and stabilize Yki protein in Drosophila S2 cells. The results in Drosophila wing discs indicate that silence of Usp10 decreases the transcription of target genes of the Hippo pathway by reducing Yki protein. In vivo functional analysis ulteriorly showed that Usp10 upregulates the Yki activity in Drosophila eyes. These findings uncover Usp10 as a novel Hippo pathway modulator and provide a new insight into the regulation of Yki protein stability and activity.